Skip to main content
ONCIMMUNE HOLDINGS PLC logo

ONCIMMUNE HOLDINGS PLC — Investor Relations & Filings

Ticker · ONC ISIN · GB00BYQ94H38 LEI · 213800HCYIWT6YPI1I02 IL Professional, scientific and technical activities
Filings indexed 362 across all filing types
Latest filing 2018-05-14 Regulatory Filings
Country GB United Kingdom
Listing IL ONC

About ONCIMMUNE HOLDINGS PLC

https://www.oncimmune.com/

Oncimmune Holdings PLC is a precision medicine and immunodiagnostics company specializing in the discovery and application of antibody and autoantibody biomarker signatures. The company's core technology is the ImmunoINSIGHTS™ platform, an advanced analytical engine for immune profiling. This platform utilizes a proprietary library of over 9,000 human antigens, bead-based multiplexed immunoassay technology, and machine learning algorithms to generate biological insights from minimal sample volumes. Oncimmune applies its expertise across therapeutic areas including immuno-oncology, autoimmune diseases, and infectious diseases. It provides biomarker discovery services, targeted panels, and advanced bioinformatics to support pharmaceutical and biotechnology partners in developing more effective and targeted treatments and diagnostics.

Recent filings

Filing Released Lang Actions
Oncimmune Launches EarlyCDT®-Liver Test in the US
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated May 14, 2018. It explicitly states that the information constitutes 'inside information stipulated under the Market Abuse Regulation' and is published via the 'Regulatory Information Service'. The content announces a significant business development: the commercial launch of a new diagnostic test (EarlyCDT®-Liver) in the US. This type of broad, material, non-financial announcement disseminated through an official regulatory service (RNS) fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (10-K, IR, ER), a management change (MANG), or a shareholder vote result (DVA). Given the source (RNS Number) and the nature of the announcement (general corporate news release), RNS is the most appropriate classification.
2018-05-14 English
PDMR Notification
Remuneration Information Classification · 99% confidence The document is titled 'PERSONS DISCHARGING MANAGER RESPONSIBILITIES (PDMR) NOTIFICATION' and details the awarding of share options to a director (Adam Hill, Chief Medical Officer and Chief Strategy Officer) and other employees. This type of filing, which reports personal share transactions or grants involving directors and executives, directly corresponds to the definition of Director's Dealing. The presence of the RNS Number and the 'END' marker suggests it is a regulatory announcement, but the specific content points strongly to DIRS over the general RNS category. The document is short and reports a specific transaction type, not the announcement of a larger report.
2018-04-23 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with 'RNS Number : 6069K' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification. Although it is distributed via RNS (Regulatory News Service), the specific content is a mandatory disclosure regarding shareholdings crossing a threshold, making 'MRQ' (Major Shareholding Notification) the most precise classification over the general 'RNS' fallback.
2018-04-11 English
Appointment of Dr Adam Hill as CMO and CSO
Board/Management Information Classification · 98% confidence The document is an official announcement disseminated via RNS (Regulatory Information Service), indicated by the 'RNS Number' and the concluding statement 'This information is provided by RNS'. The core content announces the 'Appointment of Dr Adam Hill as Chief Medical Officer and Chief Strategy Officer'. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific subject matter is management change, making MANG the most precise classification over the general RNS fallback.
2018-03-27 English
Interim Results for the half year ended 30 Nov 17
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interim Results' announcement for Oncimmune Holdings plc for the half-year ended 30 November 2017. It contains detailed financial highlights, operational updates, and a Chairman & Chief Executive's review. While it is released via an RNS (Regulatory News Service) feed, it constitutes a comprehensive interim financial report rather than a mere announcement of a report's availability. Therefore, it is classified as an Interim/Quarterly Report. H1 2017
2018-02-13 English
University of Nottingham share sale
Transaction in Own Shares Classification · 99% confidence The document begins with an 'RNS Number' and is dated February 5, 2018. The content discusses a 'University of Nottingham share sale' by a major shareholder (the University) and includes commentary from the CEO and a representative of the University's technology venture arm regarding the realization of investment value and the retention of a significant holding. This is a notification of a transaction involving a major shareholder's stake, which directly relates to changes in significant share ownership levels. This aligns best with the 'Major Shareholding Notification' (MRQ) definition. Although it is distributed via RNS, the specific subject matter is a change in a significant holding, making MRQ more precise than the general RNS fallback.
2018-02-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.